Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

A Phase I, Randomised, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Intravenous Doses of ELE-101 in Healthy Adult Participants.

To see complete record on, please visit this link

Id: NCT05434156

Organisation Name: Eleusis Therapeutics

Overal Status: Not yet recruiting

Start Date: August 2022

Last Update: August 4, 2022

Lead Sponsor: Eleusis Therapeutics

Brief Summary: A study in healthy adult participants to assess the safety and tolerability of a drug called ELE-101 and see how the body absorbs and removes the drug and how it affects the body.

  • Healthy Volunteers

Total execution time in seconds: 0.337965965271